PDSBNasdaqPharmaceutical PreparationsFiscal year ends December 31
PDS Biotechnology Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.92−0.21 (-18.89%)
Close on Oct 19, 2026
- Market cap
- $51.01M
- P/E (TTM)
- –
- Dividend yield
- –
PDS Biotechnology statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | PDS Biotechnology | Industry median |
|---|---|---|
| Market Cap | $51.30M | $166.30M |
| Enterprise Value | $45.70M | $88.19M |
Income (trailing twelve months)
| Measure | PDS Biotechnology | Industry median |
|---|---|---|
| Operating Income | -$27.83M | -$21.40M |
| Pretax Income | -$33.67M | -$14.34M |
| Net Income | -$33.67M | -$22.46M |
| EBITDA | -$27.83M | -$16.91M |
| EPS (Diluted) | -$0.65 | -$0.83 |
Returns
| Measure | PDS Biotechnology | Industry median |
|---|---|---|
| Return on Equity (ROE) | -544.0% | -53.2% |
| Return on Assets (ROA) | -136.6% | -40.9% |
Balance sheet
| Measure | PDS Biotechnology | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $5.60M | $61.43M |
| Net Cash (Debt) | $5.60M | $15.35M |
| Net Cash Per Share | $0.10 | $0.66 |
| Equity (Book Value) | -$3.58M | $49.09M |
| Book Value Per Share | -$0.06 | $1.37 |
| Tangible Book Value | -$3.58M | $23.52M |
| Working Capital | -$5.33M | $76.81M |
Financial position
| Measure | PDS Biotechnology | Industry median |
|---|---|---|
| Current Ratio | 0.57 | 3.34 |
| Quick Ratio | 0.45 | 2.44 |
| Interest Coverage | -4.18 | -6.26 |
Cash flow (trailing twelve months)
| Measure | PDS Biotechnology | Industry median |
|---|---|---|
| Operating Cash Flow | -$16.78M | -$12.35M |
Efficiency
| Measure | PDS Biotechnology | Industry median |
|---|---|---|
| Profits Per Employee | -$1.60M | -$703.34K |
| Employee Count | 21 | 74 |
Dividends and yields
| Measure | PDS Biotechnology | Industry median |
|---|---|---|
| Earnings Yield | -65.6% | -23.3% |
| Buyback Yield | -5.29% | -0.59% |
| Shareholder Yield | -5.29% | 0.00% |
Shares
| Measure | PDS Biotechnology | Industry median |
|---|---|---|
| Shares Outstanding | 55,971,300 | 58,127,000 |
| Shares Change (YoY) | 30.4% | 10.9% |
| Shares Change (QoQ) | 0.19% | 0.54% |
| Float | 34,500,500 | 49,136,700 |
| Shares Held by Insiders | 38.4% | 11.6% |
| Shares Held by Institutions | 13.7% | 59.4% |
Taxes
| Measure | PDS Biotechnology | Industry median |
|---|---|---|
| Income Tax | $0 | $79.87K |
Scores
| Measure | PDS Biotechnology | Industry median |
|---|---|---|
| Altman Z-Score | -45.82 | -0.22 |
| Piotroski F-Score | 2 | 4 |
Calculated by StockData from PDS Biotechnology's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.